Welcome to this website where you can learn more about B-cell malignancies and intracellular pathways
B-cell malignancies include most non-Hodgkin lymphomas (NHL), some leukaemias, and myelomas.1
Insights into key pathways have helped identify new targets for treating B-cell malignancies.2-5
Click here to access our resources section, which contains a range of useful documents and links with more
information about B-cell malignancies.
Click below to download the B-cell malignancies brochure.
This site is best viewed with Internet Explorer 7.0 or higher. This site is published by Janssen Pharmaceutica, NV - Turnhoutseweg 30, 2340 Beerse, Turnhout RPR nr.0403.834.160 - which is solely responsible for the content. This site is intended for European, Middle Eastern and African audiences. © Janssen Pharmaceutica, NV 2014. | Last updated: 10 December 2014